Some common problems like migraine, low energy, mood changes, and bladder symptoms often appear years before the first clear MS symptom, suggesting an early phase of the disease.
Researchers followed over 113,000 women and compared 336 who later developed MS to the rest of the group to see what changed before MS began. They found certain medical issues — for example migraine headaches, depression, leaking urine, and restless legs — were more common years before MS symptoms started. Migraine rates began to rise 9–10 years before the first MS symptom and were higher at symptom start compared with the other women. People who later developed MS also showed a drop in physical activity, physical function (how well they could do daily tasks), and vitality (energy and pep) years before symptoms. Diet did not change much before MS, so lifestyle eating patterns were less linked to this early period in the study.
People with MS or those who suspect they might be at risk should know these early signs because noticing patterns can lead to earlier conversations with doctors, similar to spotting warning lights on a car before it breaks down. Caregivers can watch for long-term trends like ongoing tiredness, headaches, mood shifts, or bladder problems and mention them to clinicians, which may speed evaluation or support. Healthcare providers may use this information to ask more detailed questions about symptoms that started years earlier, helping them see a fuller picture. This matters for daily life because small changes — less walking, more fatigue, or new bladder leakage — might be the first clues and deserve practical help like physiotherapy, energy pacing, or bladder management. People who have family history of MS or unexplained new problems should pay extra attention, but anyone with persistent, unexplained changes can benefit from sharing them with a clinician.
This study followed only women in a nurses' cohort, so results may not be the same for men or other groups, which matters because MS can act differently across people. The study shows links but cannot prove these early signs cause MS — they may be clues that something is changing, not guarantees of MS. Also, many people without MS will have headaches, low energy, or bladder changes, so these signs alone do not mean someone has or will get MS.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More7/1/2026
MRI shows the choroid plexus is larger early in MS and links to inflammation and certain genes, sugg
Read More7/1/2026
A case shows rheumatoid arthritis can inflame the brain lining and cause focal seizures; prompt diag
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.